Melanotan II
Educational information only — not medical advice. Many listed compounds are not FDA-approved for human use. Consult a licensed clinician before starting, changing, or stopping any protocol.
Overview
Melanotan II is a synthetic cyclic peptide modeled on alpha-melanocyte-stimulating hormone (alpha-MSH), a hormone the body uses to regulate skin pigmentation. It is most often discussed in the context of tanning, where it is studied for its ability to darken the skin.
Unlike a topical product, Melanotan II acts systemically on melanocortin receptors. It has also been investigated for effects on sexual function and appetite, reflecting the range of receptors it can activate. Much of the human data comes from small early-phase studies conducted decades ago.
Melanotan II is not approved by any major regulator for therapeutic use and is widely sold in an unregulated research-chemical market. It is closely related to, but distinct from, afamelanotide (sometimes called Melanotan I), a more receptor-selective peptide that has been approved for a specific rare condition.
How it works
Melanotan II binds melanocortin receptors, including MC1R on melanocytes. Activating MC1R stimulates the production of eumelanin, the darker pigment associated with tanning, which is why a UV-driven tan is commonly reported to develop faster and appear deeper. Because it is a broad melanocortin agonist, it can also engage receptors such as MC3R and MC4R.
That broader activity is thought to explain effects beyond pigmentation reported in the literature, including changes in appetite and libido. The precise pharmacology in humans is not fully characterized, and evidence remains limited.
Reported benefits
- Accelerated or deepened tanning when combined with UV exposure (studied in small human trials)
- Reduced time and sun exposure needed to reach a given level of tan (reported)
- Effects on libido and sexual function (studied in early research)
These are reported or studied effects, not guaranteed outcomes, and are not endorsements of use.
Considerations & side effects
Commonly reported short-term side effects include nausea, facial flushing, appetite suppression, and spontaneous erections. Users frequently report darkening of existing moles and freckles and the appearance of new pigmented spots, which dermatology sources flag as a concern because such changes can complicate monitoring for skin cancer. More serious adverse events, including rhabdomyolysis and neurological syndromes, have been described in case reports.
Because Melanotan II is unlicensed and sold outside regulated supply chains, product purity, sterility, and dosing accuracy vary widely, and long-term safety in humans is not well established. It is not a substitute for evaluation and treatment by a qualified clinician.
Frequently asked
What is Melanotan II?
A synthetic cyclic peptide analog of alpha-melanocyte-stimulating hormone (alpha-MSH) that activates melanocortin receptors and is studied primarily for its effect on skin pigmentation.
Is Melanotan II FDA-approved?
No. Melanotan II is not approved by the FDA or licensed by other major regulators for human use, and is sold for research purposes only.
Does Melanotan II work without sun exposure?
It stimulates melanin production, but a visible tan generally still requires ultraviolet exposure. Peptide-driven pigmentation is reported to accelerate or deepen tanning rather than replace UV entirely.
How is Melanotan II different from afamelanotide (Melanotan I)?
Afamelanotide is a more MC1R-selective peptide that has gained regulatory approval for a specific rare condition. Melanotan II activates melanocortin receptors more broadly, which is thought to underlie both its wider range of reported effects and its side effects.
References
Related compounds
Synthetic analog of alpha-MSH that stimulates melanin production for photoprotection. Milder side effect profile than Melanotan II. FDA-approved implant form (Scenesse) exists for EPP.
A long-acting dopamine agonist used to lower elevated prolactin, which can impair libido and erectile function on TRT or with certain compounds. Dosed only twice weekly thanks to its ~65-hour half-life; monitor for valvular effects at higher doses.
Dehydroepiandrosterone, an adrenal precursor hormone the body converts into testosterone and estrogen. Supplemented by men and women for hormone support, energy, and libido, often as part of an anti-aging or HRT stack.